Pfizer Submitting Research Hoping FDA Approves Vaccine For Ages 5 to 11


What do you think about our kids having access to a COVID-19 vaccine?

Pfizer released early research data from its vaccine trial on kids ages 5 to 11. Apparently they found a "robust" antibody response so it's looking like the children will be next in line to get the shot.

In a press release, the company explained that kids in the trial received two shots of a smaller dose than what teens and adults received. Turns out results are similar, including the immune-system response. Side effects were also the same as they are for teens and young adults.

The data is being sent to the Food and Drug Administration "ASAP" with the expectation of getting emergency approval soon. Reportedly, children make up about 30% of all new COVID cases in the country today.

We're wondering what the percentage of parents willing to get their child vaccinated will be.......


Sponsored Content

Sponsored Content